American Urological Association (AUA) Guideline on prostate cancer detection: process and rationale

Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement

(2013) Virginia A. Moyer   ANNALS OF INTERNAL MEDICINE

Comparative Effectiveness of Alternative Prostate-Specific Antigen–Based Prostate Cancer Screening Strategies

(2013) Roman Gulati et al.   ANNALS OF INTERNAL MEDICINE

How to Decide Whether a Clinical Practice Guideline Is Trustworthy

(2013) David F. Ransohoff et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Prostate Cancer Mortality in the Finnish Randomized Screening Trial

(2013) T. P. Kilpelainen et al.   JNCI-Journal of the National Cancer Institute

Early Detection of Prostate Cancer: AUA Guideline

(2013) H. Ballentine Carter et al.   JOURNAL OF UROLOGY

Natural History of Early, Localized Prostate Cancer: A Final Report from Three Decades of Follow-up

(2012) Marcin Popiolek et al.   EUROPEAN UROLOGY

Prostate-Cancer Mortality at 11 Years of Follow-up

(2012) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Radical Prostatectomy versus Observation for Localized Prostate Cancer

(2012) Timothy J. Wilt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prostate cancer epidemiology in the United States

(2012) Otis W. Brawley   WORLD JOURNAL OF UROLOGY

What If I Don't Treat My PSA-Detected Prostate Cancer? Answers from Three Natural History Models

(2011) R. Gulati et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer

(2011) Anna Bill-Axelson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical practice guidelines to inform evidence-based clinical practice

(2011) J. Stuart Wolf et al.   WORLD JOURNAL OF UROLOGY

Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50

(2010) Hans Lilja et al.   CANCER

Empirical Estimates of the Lead Time Distribution for Prostate Cancer Based on Two Independent Representative Cohorts of Men Not Subject to Prostate-Specific Antigen Screening

(2010) C. J. Savage et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

(2010) Jonas Hugosson et al.   LANCET ONCOLOGY

A Model of Prostate-Specific Antigen Screening Outcomes for Low- to High-Risk Men

(2009) Kirsten Howard et al.   ARCHIVES OF INTERNAL MEDICINE

Staying at the cutting edge: a review and analysis of evidence reporting and grading; the recommendations of the American Urological Association

(2009) Martha Faraday et al.   BJU INTERNATIONAL

Prostate Specific Antigen Testing Among the Elderly—When To Stop?

(2009) Edward M. Schaeffer et al.   JOURNAL OF UROLOGY

Prostate Specific Antigen Best Practice Statement: 2009 Update

(2009) Kirsten L. Greene et al.   JOURNAL OF UROLOGY

Mortality Results from a Randomized Prostate-Cancer Screening Trial

(2009) Gerald L. Andriole et al.   NEW ENGLAND JOURNAL OF MEDICINE

Screening and Prostate-Cancer Mortality in a Randomized European Study

(2009) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE